<SEC-DOCUMENT>0001415889-23-008658-index.html : 20230523
<SEC-HEADER>0001415889-23-008658.hdr.sgml : 20230523
<ACCEPTANCE-DATETIME>20230523180010
ACCESSION NUMBER:		0001415889-23-008658
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230519
FILED AS OF DATE:		20230523
DATE AS OF CHANGE:		20230523

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gillies Hunter
		CENTRAL INDEX KEY:			0001868997

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40544
		FILM NUMBER:		23950053

	MAIL ADDRESS:	
		STREET 1:		C/O AEROVATE THERAPEUTICS, INC.
		STREET 2:		200 BERKELEY STREET, FLOOR 18
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aerovate Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001798749
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831377888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		930 WINTER STREET
		STREET 2:		SUITE M-500
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-443-2400

	MAIL ADDRESS:	
		STREET 1:		930 WINTER STREET
		STREET 2:		SUITE M-500
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-05232023_060501.xml
<TEXT>
Document 1 - file: form4-05232023_060501.html

Document 1 - RAW XML: form4-05232023_060501.xml

</DOCUMENT>
</SEC-DOCUMENT>